Cotización - PHST

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

5.48

Postura de Compra

0.00

Postura de Venta

0.00

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

5.48

Precio de Apertura

Hora

Última hora de negociación

Volumen promedio (3 m)

Volumen financiero

Precio Promedio Ponderado

Pharsight Launches PK Accelerator(TM)

PK Accelerator Bundled Solution Accelerates Pharmacokinetic Analysis and Reporting MOUNTAIN VIEW, Calif., June 24 /PRNewswire-FirstCall/...

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Talk Will Cover the Use of Pharsight Software for In-Vitro / In-Vivo Correlation Modeling in Drug Development MOUNTAIN VIEW, Calif., June 23...

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Dr. Farkad Ezzet Will Present on the Strategic Value of Literature Modeling to Assess Disease Progression and Drug Attributes in Clinical...

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Dr. Laurent Claret Will Present Case Studies on the Value of Drug-Disease Modeling to Predict Efficacy and Survival Benefits of Anticancer Agents...

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Dr. Robert Leary Will Discuss Computational Methods for Model Evaluation; Dr. Mike Dunlavey Will Present Simplified Programming Approaches of...

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Dr. Helen Kastrissios Will Present on Communicating the Value of Pharmacodynamic Modeling in Clinical Drug Development MOUNTAIN VIEW, Calif., May...

Pharsight Hosts European PKS User Meeting

Second Annual European Meeting to be Held In Paris MOUNTAIN VIEW, Calif., May 23 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST...

Pharsight Achieves $7.6 Million In Quarterly Revenue

Fourth Quarter Revenue Highest in Company History; Full Year Revenue Up 13% MOUNTAIN VIEW, Calif., May 8 /PRNewswire-FirstCall/ -- Pharsight...

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Dr. Bill Poland Will Present on the Strategic Use of Incorporating Adherence Data into Clinical Trial Predictions of Antiviral Therapies MOUNTAIN...

Pharsight Strengthens Senior Management Team

John Murphy Appointed as New Senior Vice President of Consulting Services MOUNTAIN VIEW, Calif., April 29 /PRNewswire-FirstCall/ -- Pharsight...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

PHST - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de ?

El precio actual de las acciones de es US$ 5.48

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de ?

ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
TNONTenon Medical Inc	US$ 1.5298 (55.40%)	3.57M
TROOTROOPS Inc	US$ 1.05 (25.00%)	480.27k
STFSStar Fashion Culture Holdings Ltd	US$ 1.2299 (14.35%)	402.11k
ADGMAdagio Medical Holdings Inc	US$ 0.9091 (11.68%)	329
UPLDUpland Software Inc	US$ 3.6999 (11.61%)	430
IMTEIntergrated Media Technology Ltd	US$ 1.70 (-17.48%)	884.76k
PROPPrairie Operating Company	US$ 4.89 (-16.55%)	21.81k
VVPRVivoPower International PLC	US$ 2.7515 (-14.28%)	1.03M
TRSGTungray Technologies Inc	US$ 1.77 (-13.66%)	1.02M
SGLYSingularity Future Technology Ltd	US$ 1.30 (-12.75%)	19.66k
TNONTenon Medical Inc	US$ 1.5298 (55.40%)	3.57M
MCHIiShares MSCI China	US$ 55.5981 (-0.06%)	2.44M
NVDANVIDIA Corporation	US$ 121.28 (0.03%)	2.24M
HOLOMicroCloud Hologram Inc	US$ 1.09 (-1.00%)	1.85M
TLTiShares 20 plus Year Treasury Bond	US$ 89.65 (-0.12%)	1.75M

No se encontraron comentarios

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Pharsight Corp (MM) (PHST)

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

PHST Últimas noticias

Pharsight Launches PK Accelerator(TM)

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Pharsight Hosts European PKS User Meeting

Pharsight Achieves $7.6 Million In Quarterly Revenue

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Pharsight Strengthens Senior Management Team

PHST - Preguntas Frecuentes

Movimientos

PHST Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Pharsight Corp (MM) (PHST) Cotización

Pharsight Corp (MM) (PHST)

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

PHST Últimas noticias

Pharsight Launches PK Accelerator(TM)

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Pharsight Hosts European PKS User Meeting

Pharsight Achieves $7.6 Million In Quarterly Revenue

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Pharsight Strengthens Senior Management Team

PHST - Preguntas Frecuentes

Movimientos

PHST Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Quitar anuncios

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS